» Articles » PMID: 21422202

Effect of Antibiotic Treatment on Establishment and Elimination of Intestinal Colonization by KPC-producing Klebsiella Pneumoniae in Mice

Overview
Specialty Pharmacology
Date 2011 Mar 23
PMID 21422202
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

An understanding of the impact of antibiotics on the intestinal reservoir of KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is important to prevent its emergence. We used a mouse model to examine the effect of antibiotic treatment on the establishment and elimination of intestinal colonization with KPC-Kp. Mice (10 per group) received subcutaneous antibiotics daily for 8 days. On day 3 of treatment, 10(3) CFU of KPC-Kp was given orogastrically, and concentrations of KPC-Kp in stool were monitored. Additional experiments assessed the effects of antibiotic treatment on concentrations of total anaerobes and Bacteroides spp. in stool and the efficacy of orogastric gentamicin and polymyxin E in suppressing KPC-Kp colonization. Of four antibiotics with minimal activity against the KPC-Kp test strain (MIC ≥ 16 μg/ml), those that suppressed total anaerobes and bacteroides (i.e., clindamycin and piperacillin-tazobactam) promoted colonization by KPC-Kp (P < 0.001), whereas agents that did not suppress total anaerobes or bacteroides (i.e., ciprofloxacin and cefepime) did not (P = 0.35). Of two agents with moderate activity against the KPC-Kp test strain, ertapenem (MIC, 4 μg/ml) did not promote colonization by KPC-Kp, whereas tigecycline (MIC, 3 μg/ml) did (P < 0.001), despite not reducing levels of total anaerobes or bacteroides. Orogastric treatment with gentamicin and polymyxin E suppressed KPC-Kp to undetectable levels in the majority of mice. These data suggest that antibiotics that disturb the intestinal anaerobic microflora and lack significant activity against KPC-Kp promote colonization by this organism. The administration of nonabsorbed oral antibiotics may be an effective strategy to suppress colonization with KPC-Kp.

Citing Articles

Effect of Ceftaroline, Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam on Establishment of Colonization by Vancomycin-Resistant Enterococci and in Mice.

Hausman B, Memic S, Cadnum J, Zink E, Wilson B, Donskey C Pathog Immun. 2024; 9(2):194-204.

PMID: 39345792 PMC: 11432534. DOI: 10.20411/pai.v9i2.711.


A new model of intestinal colonization using larvae: testing hyperepidemic ESBL- and carbapenemase-producing clones.

Eddoubaji Y, Aldeia C, Campos-Madueno E, Moser A, Kundlacz C, Perreten V Front Microbiol. 2024; 15:1381051.

PMID: 38659985 PMC: 11039899. DOI: 10.3389/fmicb.2024.1381051.


Deciphering the gastrointestinal carriage of .

Bray A, Zafar M Infect Immun. 2024; 92(9):e0048223.

PMID: 38597634 PMC: 11384780. DOI: 10.1128/iai.00482-23.


Animal models of mucosal infections.

Assoni L, Couto A, Vieira B, Milani B, Lima A, Converso T Front Microbiol. 2024; 15:1367422.

PMID: 38559342 PMC: 10978692. DOI: 10.3389/fmicb.2024.1367422.


Antibiotics in anesthesia and critical care.

Premachandra A, Moine P Ann Transl Med. 2024; 12(1):6.

PMID: 38304898 PMC: 10777233. DOI: 10.21037/atm-22-5585.


References
1.
Donskey C . Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli. Clin Infect Dis. 2006; 43 Suppl 2:S62-9. DOI: 10.1086/504481. View

2.
Nord C, Sillerstrom E, Wahlund E . Effect of tigecycline on normal oropharyngeal and intestinal microflora. Antimicrob Agents Chemother. 2006; 50(10):3375-80. PMC: 1610089. DOI: 10.1128/AAC.00373-06. View

3.
Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R . Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009; 30(7):666-71. DOI: 10.1086/598244. View

4.
Nordmann P, Cuzon G, Naas T . The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009; 9(4):228-36. DOI: 10.1016/S1473-3099(09)70054-4. View

5.
Queenan A, Bush K . Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007; 20(3):440-58, table of contents. PMC: 1932750. DOI: 10.1128/CMR.00001-07. View